<bill session="118" type="s" number="2916" updated="2025-11-19T03:44:08Z">
  <state datetime="2023-09-26">REFERRED</state>
  <status>
    <introduced datetime="2023-09-26"/>
  </status>
  <introduced datetime="2023-09-26"/>
  <titles>
    <title type="display">Prescription Information Modernization Act of 2023</title>
    <title type="short" as="introduced">Prescription Information Modernization Act of 2023</title>
    <title type="official" as="introduced">A bill to provide for digital communication of prescribing information for drugs (including biological products), and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B001288"/>
  <cosponsors>
    <cosponsor bioguide_id="B001305" joined="2023-12-06"/>
    <cosponsor bioguide_id="M001190" joined="2023-09-26"/>
  </cosponsors>
  <actions>
    <action datetime="2023-09-26">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-09-26" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="1503" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2023-10-26T19:30:20Z" status="Introduced in Senate">Prescription Information Modernization Act of 2023

This bill allows health care providers to receive prescribing information for drugs electronically rather than in paper form from manufacturers. Manufacturers must still give providers the option to continue to receive or request the information in paper form.

Additionally, the Food and Drug Administration must hold a public workshop to discuss with stakeholders how to optimize the format, accessibility, and usability of prescribing information.</summary>
</bill>
